Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050440
Status:
COMPLETED
Last Update Posted:
2013-01-08
First Post:
2002-12-09
Brief Title:
Phase 2 Study of ET-743 Trabectedin in Patients With Persistent or Recurrent Endometrial Carcinoma
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Endometrial Neoplasms |
| Uterine Neoplasms |
| Genital Neoplasms Female Urogenital Neoplasms |